Registration Page: https://www.eventbrite.com/e/life-science-spacs-insights-from-the-field-tickets-150172693569
About this event:
The past year(+) can be described in many ways, but “the year of the SPAC” and the “greatest year ever for the biopharma industry” are two ways to go. You merge those two together, and you have the NEVCA’s next Member Edu session: “Life Science SPACs – Insights from the Field.”
For this upcoming Member Edu session, we’re bringing together heavy weights in the life science innovation industry – Kevin Bitterman, Partner at Atlas Venture; Dan Dubin, Vice Chairman and Head of Biopharma Investment Banking at SVB Leerink; and Jason Meyenburg, Chief Executive Officer at Gemini Therapeutics. They’ll be discussing trends and insights from their personal experiences within the healthcare SPAC marketplace.
After the conversation, join the NEVCA , other attendees and the speakers for a Rally Video networking session – an opportunity to engage on the subject matter. Don’t miss this valuable learning opportunity, register today!
2pm: Introduction by the NEVCA
2:05pm: Panelist Discussion with Kevin Bitterman, Atlas Venture, Dan Dubin, SVB Leerink & Jason Meyenburg, Gemini Therapeutics
2:40pm: Networking Session on Rally Video